Clinical Trials Logo

Filter by:
NCT ID: NCT05495776 Recruiting - Colorectal Cancer Clinical Trials

Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer

MSIRus22
Start date: August 1, 2022
Phase:
Study type: Observational [Patient Registry]

Prospective multicenter registry study to assess the frequency of Lynch syndrome among patients with colorectal cancer in Russia

NCT ID: NCT05494606 Recruiting - Ulcerative Colitis Clinical Trials

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

PROFUNDUS
Start date: August 15, 2022
Phase:
Study type: Observational

Ulcerative colitis (UC) is an idiopathic, chronic, inflammatory disease affecting the colon. Participants with UC have mucosal inflammation starting in the rectum that can extend continuously to proximal segments of the colon. This study will assess how safe and effective upadacitinib is in treating adult participants with moderate to severe ulcerative colitis (UC). Adverse events and change in disease activity will be assessed. Upadacitinib is a drug approved for the treatment of Ulcerative colitis (UC). All study participants will receive upadacitinib as prescribed by their study doctor in accordance with approved local label. Approximately 1000 adult participants will be enrolled worldwide. Participants will receive upadacitinib as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 3 years. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

NCT ID: NCT05490862 Recruiting - Obesity Clinical Trials

Inflammatory Status of Monocytes in Obesity

Start date: January 11, 2022
Phase: N/A
Study type: Interventional

The study of the pro-inflammatory activation of circulating monocytes/macrophages in obesity is the main problem of this project. The investigation of pro-inflammatory activation of monocytes and determination of the level of mitochondrial genome mutations, assessment of traditional CVD risk factors and the degree of cardiovascular risk and atherosclerosis indicators and their association will be investigated in dynamics on 12-weeks weight loss.

NCT ID: NCT05487053 Recruiting - Clinical trials for Osteo Arthritis Knee

The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement

Start date: February 3, 2024
Phase: N/A
Study type: Interventional

Total knee replacement (TKR) is considered the most effective and safe method of radical treatment of late stages of knee osteoarthritis. A well-known problem of TKR is a severe postoperative pain syndrome, which is observed in more than 50% of patients. Femoral nerve block (FNB) is the "gold standard" for continuous postoperative analgesia after total knee replacement, as it is effective in reducing the frequency of use of opioid analgetics and reduce the duration of hospitalization. At the same time, the negative effect of this method is the motor blockade of the quadriceps femoris muscle which leads to functional impairment and is associated with an increased risk of falling. Adductor canal block (ACB) provides adequate analgesia comparable to femoral nerve block. Moreover, ACB doesn't affect the motor function of the quadriceps femoris muscle. The possibility of enhanced recovery after total knee replacement is the reason to compare single-shot adductor canal block and continuous femoral nerve block.

NCT ID: NCT05485038 Recruiting - Glioma, Malignant Clinical Trials

General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas

GAMMA
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Objective of the study is to determine whether resection of gliomas and metastases of motor areas using awake surgery can achieve rarer motor deterioration after operation than using general anesthesia.

NCT ID: NCT05484245 Recruiting - Clinical trials for Arteriovenous Malformations

Sonography-guided Resection of Brain Mass Lesions

SOMALI
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Objective of the study is to determine possibilities of intraoperative sonography in detecting of various brain mass lesions, assessing extent of their resection and define indications to use ultrasound-guided needle or ultrasound wire-guided port.

NCT ID: NCT05484219 Recruiting - Clinical trials for Arteriovenous Malformations

Functional Navigation in Surgery of Cerebral Tumors and Vascular Malformations

FUN
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to assess accuracy, advantages of functional neuronavigation and calculate safe distance from motor areas to brain tumors and vascular malformations in image-guided surgery.

NCT ID: NCT05477680 Recruiting - Clinical trials for Arteriovenous Malformations

Intraoperative Brain Shift Calculation Study

BRASH
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to calculate magnitude, type of intraoperative brain shift and assess possibility of it's prediction.

NCT ID: NCT05475522 Recruiting - Metastases to Brain Clinical Trials

Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain Metastases

SONOFLUO
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Objective of the study is to determine whether intraoperative ultrasound guided resection of gliomas with contrast enhancement in magnetic resonance imaging and brain metastases can achieve as high rate of gross total resection as fluorescence-guided surgery with 5-aminolevulinic acid

NCT ID: NCT05474573 Recruiting - Glioma, Malignant Clinical Trials

Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases

CONFLUENSE
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Objective of the study is to determine whether combined use of intraoperative fluorescence with 5-aminolevulinic acid (5-ALA) and sonography can achieve higher rate of gross total resection of contrast-enhancing gliomas and brain metastases compared to intraoperative fluorescence with 5-ALA alone.